Work

Comment on Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434

Year: 2024

Type: letter

Abstract: We noted three key inconsistencies in the Moderna-funded cost-effectiveness analysis by Fust et al [...].

Source: Vaccines

DOI: 10.3390/vaccines12101174

Authors: Hannah R. Volkman, Jennifer L. Nguyen, Mustapha M. Mustapha, Luis Jodar, John M. McLaughlin

Institution: Pfizer (United States)

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,069

Funder: Pfizer

OpenAlex ID: W4403494000

Cites: 11

Cited by: 1

Related to: 10